Trial
NCT00392782
Donor Stem Cell Transplant in Treating Patients With Myeloid Cancer or Other Disease
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Masonic Cancer Center, University of Minnesota
Collaborators
Center for International Blood and Marrow Transplant Research
Condition
Leukemia
Intervention
anti-thymocyte globulin
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-12-28